Liraglutide also showed a beneficial effect, though less pronounced, with an 18% reduced risk
Expanding Indications: Approval for obesity, and potential approval for cardiovascular risk reduction in patients with diabetes or obesity, will significantly broaden its patient base
Research comparing GLP-1 based therapies on muscle mass found that skeletal muscle changes during treatment appear to be adaptive rather than degenerative
doi: 10.1016/j.brainres.2018.04.031
Another form of renal toxicity, generally associated with NSAIDs, is seen in patients with prerenal conditions leading to the reduction in renal blood flow or blood volume, where the renal prostaglandins have a supportive role in maintaining renal perfusion
Storage And Handling Store EGRIFTA WR 11.6 mg vial at room temperature at 20C to 25C (68F to 77F) in the original box to protect from light